Abeona Therapeutics

Abeona Therapeutics is an Ohio-based biotech firm developing novel gene and cell therapies for the treatment of individuals with rare diseases.

The company's pipeline includes potential treatments for recessive dystrophic epidermolysis bullosa (RDEB), Batten Disease and Sanfilippo Syndrome.

Abeona trades on the Nasdaq exchange (symbol: $ABEO), and completed post-IPO equity fundraising in October 2017, raising $92 million.

Latest Abeona Therapeutics News & Features

23 April 2024

28 November 2023

12 June 2023

1 December 2022